Table of Contents

2019-2024 Global Intravenous (IV) Ibuprofen Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Intravenous (IV) Ibuprofen Consumption 2014-2024
  • 2.1.2 Intravenous (IV) Ibuprofen Consumption CAGR by Region
• 2.2 Intravenous (IV) Ibuprofen Segment by Type
  • 2.2.1 100 mg Dose
  • 2.2.2 200 mg Dose
  • 2.2.3 400 mg Dose
  • 2.2.4 800 mg Dose
• 2.3 Intravenous (IV) Ibuprofen Consumption by Type
  • 2.3.1 Global Intravenous (IV) Ibuprofen Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Intravenous (IV) Ibuprofen Sale Price by Type (2014-2019)
• 2.4 Intravenous (IV) Ibuprofen Segment by Application
  • 2.4.1 Pain
  • 2.4.2 Fever
  • 2.4.3 Inflammation
• 2.5 Intravenous (IV) Ibuprofen Consumption by Application
  • 2.5.1 Global Intravenous (IV) Ibuprofen Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Intravenous (IV) Ibuprofen Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Intravenous (IV) Ibuprofen Sale Price by Application (2014-2019)

3 Global Intravenous (IV) Ibuprofen by Players

• 3.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Players
  • 3.1.1 Global Intravenous (IV) Ibuprofen Sales by Players (2017-2019)
  • 3.1.2 Global Intravenous (IV) Ibuprofen Sales Market Share by Players (2017-2019)
• 3.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Players
  • 3.2.1 Global Intravenous (IV) Ibuprofen Revenue by Players (2017-2019)
  • 3.2.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Players (2017-2019)
• 3.3 Global Intravenous (IV) Ibuprofen Sale Price by Players
• 3.4 Global Intravenous (IV) Ibuprofen Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Intravenous (IV) Ibuprofen Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Intravenous (IV) Ibuprofen Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Intravenous (IV) Ibuprofen by Regions

• 4.1 Intravenous (IV) Ibuprofen by Regions
  • 4.1.1 Global Intravenous (IV) Ibuprofen Consumption by Regions
  • 4.1.2 Global Intravenous (IV) Ibuprofen Value by Regions
• 4.2 Americas Intravenous (IV) Ibuprofen Consumption Growth
• 4.3 APAC Intravenous (IV) Ibuprofen Consumption Growth
• 4.4 Europe Intravenous (IV) Ibuprofen Consumption Growth
• 4.5 Middle East & Africa Intravenous (IV) Ibuprofen Consumption Growth

5 Americas

• 5.1 Americas Intravenous (IV) Ibuprofen Consumption by Countries
  • 5.1.1 Americas Intravenous (IV) Ibuprofen Consumption by Countries (2014-2019)
  • 5.1.2 Americas Intravenous (IV) Ibuprofen Value by Countries (2014-2019)
• 5.2 Americas Intravenous (IV) Ibuprofen Consumption by Type
• 5.3 Americas Intravenous (IV) Ibuprofen Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Intravenous (IV) Ibuprofen Consumption by Countries
  • 6.1.1 APAC Intravenous (IV) Ibuprofen Consumption by Countries (2014-2019)
  • 6.1.2 APAC Intravenous (IV) Ibuprofen Value by Countries (2014-2019)
• 6.2 APAC Intravenous (IV) Ibuprofen Consumption by Type
• 6.3 APAC Intravenous (IV) Ibuprofen Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Intravenous (IV) Ibuprofen by Countries
  • 7.1.1 Europe Intravenous (IV) Ibuprofen Consumption by Countries (2014-2019)
  • 7.1.2 Europe Intravenous (IV) Ibuprofen Value by Countries (2014-2019)
• 7.2 Europe Intravenous (IV) Ibuprofen Consumption by Type
• 7.3 Europe Intravenous (IV) Ibuprofen Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Intravenous (IV) Ibuprofen by Countries
  • 8.1.1 Middle East & Africa Intravenous (IV) Ibuprofen Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Intravenous (IV) Ibuprofen Value by Countries (2014-2019)
• 8.2 Middle East & Africa Intravenous (IV) Ibuprofen Consumption by Type
• 8.3 Middle East & Africa Intravenous (IV) Ibuprofen Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Intravenous (IV) Ibuprofen Distributors
• 10.3 Intravenous (IV) Ibuprofen Customer

11 Global Intravenous (IV) Ibuprofen Market Forecast

• 11.1 Global Intravenous (IV) Ibuprofen Consumption Forecast (2019-2024)
• 11.2 Global Intravenous (IV) Ibuprofen Forecast by Regions
  • 11.2.1 Global Intravenous (IV) Ibuprofen Forecast by Regions (2019-2024)
  • 11.2.2 Global Intravenous (IV) Ibuprofen Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Intravenous (IV) Ibuprofen Forecast by Type
• 11.8 Global Intravenous (IV) Ibuprofen Forecast by Application

12 Key Players Analysis

• 12.1 Cumberland Pharmaceuticals
  • 12.1.1 Company Details
  • 12.1.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Cumberland Pharmaceuticals News
• 12.2 Alveda Pharmaceuticals
  • 12.2.1 Company Details
  • 12.2.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Alveda Pharmaceuticals News
• 12.3 CSL Limited
  • 12.3.1 Company Details
  • 12.3.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 CSL Limited News
• 12.4 Sandor Medicaids
  • 12.4.1 Company Details
  • 12.4.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Sandor Medicaids News
• 12.5 PT. Soho Industri Pharmasi
  • 12.5.1 Company Details
  • 12.5.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 PT. Soho Industri Pharmasi News
• 12.6 Germin MED
  • 12.6.1 Company Details
  • 12.6.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Germin MED News
• 12.7 Grifols
  • 12.7.1 Company Details
  • 12.7.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Grifols News
• 12.8 Gloria Pharmaceuticals
  • 12.8.1 Company Details
  • 12.8.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Gloria Pharmaceuticals News
• 12.9 Al Nabeel International
  • 12.9.1 Company Details
  • 12.9.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Al Nabeel International News
• 12.10 Laboratorios Valmorca
  • 12.10.1 Company Details
  • 12.10.2 Intravenous (IV) Ibuprofen Product Offered
  • 12.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Laboratorios Valmorca News

13 Research Findings and Conclusion

Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.

According to this study, over the next five years the Intravenous (IV) Ibuprofen market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravenous (IV) Ibuprofen business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous (IV) Ibuprofen market by product type, application, key manufacturers and key regions and countries.

This study considers the Intravenous (IV) Ibuprofen value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pain
Fever
Inflammation

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Intravenous (IV) Ibuprofen consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Intravenous (IV) Ibuprofen market by identifying its various subsegments.
Focuses on the key global Intravenous (IV) Ibuprofen manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravenous (IV) Ibuprofen with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Intravenous (IV) Ibuprofen submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.